AzTrials
AzTrials

Prolapse; FemaleNCT06128291

Concomitant Posterior Colporrhaphy on Bowel Functions in Pelvic Organ Prolapse Repair

An observational study of Prolapse; Female, run by National Taiwan University Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Compare the changes of preoperative and postoperative posterior colporrhaphy. Read more about this study

Who is it for?
Ages 20 to 100 years, women only
Conditions the study is for
Prolapse; Female
What is being tested?
posterior colporrhaphy
Type of treatment
Surgery or procedure
How many people
283 participants
Where
1 siteTaiwan
Study dates
3 Mar 2023to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 100 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: women with pelvic organ prolapse planned to receive concomitant posterior colporrhaphy

Who may be able to join

  • women with pelvic organ prolapse planned to receive concomitant posterior colporrhaphy

Who cannot join

  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • National Taiwan University Hospital

    Taipei

Other trials in Taiwan

About this study

Official title: The Impact of Concomitant Posterior Colporrhaphy on Bowel Functions in Women Who Received Pelvic Organ Prolapse Repair

Compare the changes of preoperative and postoperative posterior colporrhaphy.

Read the detailed description

Introduction:

Concomitant posterior colporrhaphy was frequently used during pelvic organ prolapse repair.

Objectives:

To evaluate the correlation between the presence of bowel symptoms and s rectocele severity and elucidate the impact of posterior colporrhaphy on bowel functions.

Methods:

Medical records of all consecutive women who received concomitant posterior colporrhaphy for their pelvic organ prolapse repairs were reviewed. In general, all women were requested to answer bowel incontinence assessment questionnaires before and after surgery.

Possible results:

Differences in rectocele severities between the presence or absence of fecal incontinence, flatus incontinence, constipation, diarrhea or sensation of residual stool will be shown.

Being tested
posterior colporrhaphy
Medical subject headings
Prolapse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • posterior colporrhaphyProcedure or surgery

    posterior colporrhaphy for rectocele.

Study groups in NCT06128291
Study groupRoleWhat they receive
Posterior colporrhaphyMedical records of women received concomitant posterior colporrhaphy for their pelvic organ prolapse repairs. Comparison will be made to compare preoperative and postoperative conditions.
Receives: Procedure: posterior colporrhaphy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with fecal incontinence

    Number of participants present the symptom

    Measured: before the operation, postoperative one month and three months.

  2. Number of participants with flatus

    Number of patients present the symptom

    Measured: before the operation, postoperative one month and three months.

  3. Number of participants with constipation

    Number of patients present the symptom

    Measured: before the operation, postoperative one month and three months.

  4. Number of participants with diarrhea

    Number of patients present the symptom

    Measured: before the operation, postoperative one month and three months.

  5. Number of participants with sensation of residual stool

    Number of patients present the symptom

    Measured: before the operation, postoperative one month and three months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2023
  2. Study start3 Mar 2023
  3. Primary completion3 Apr 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
283 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06128291
Sponsor's protocol ID
202303052RINA
Status last verified
Oct 2024
First submitted
7 Nov 2023
Last updated
18 Oct 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Prolapse; Female, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with fecal incontinence (time frame: before the operation, postoperative one month and three months.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in